SARS-CoV-2/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test. Ref: IRT-ACO555
- Risk class
- III
- Product type
- In Vitro Diagnostic
- Commercial name
- 19-937 IVD Reagents/Assay Kits, Immunoassay, Rapid
- Analysis ID
- 3e87b492bb17aef6a99e40187344d6dd
- Registration date
- January 25, 2023
- Expiration date
- January 25, 2028
- City
- MONTCLAIR
- Country
- UNITED STATES
- Address
- 4650 ARROW HIGHWAY SUITE D6, MONTCLAIR, CA 91763
- Name
- ACRO BIOTECH, INC.
- Country
- UNITED STATES
- Address
- URB BELLAVISTA ALTA 3RD TRANSVERSAL N61-37 AND SABANILLA
- Phone
- 2293537
FOR THE QUALITATIVE DETECTION OF SARS-COV-2, INFLUENZA A, INFLUENZA B, RESPIRATORY SYNCYTIAL VIRUS (RSV), ADENOVIRUS, AND MYCOPLASMA PNEUMONIAE ANTIGENS IN NASOPHARYNGEAL SWAB SPECIMENS
Access comprehensive regulatory information for SARS-CoV-2/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test. Ref: IRT-ACO555 in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID 3e87b492bb17aef6a99e40187344d6dd and manufactured by ACRO BIOTECH, INC.. The device was registered on January 25, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.